Michael Martin, MD, MBA is affiliated with Takeda Pharmaceuticals USA, Inc., Lexington, Massachusetts. Michael Martin has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2023 and 2024. Their work focuses on Attention-Deficit/Hyperactivity Disorder, Child and Adolescent Psychiatry, and COVID.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
